The primary benefit of using the UCSF Criteria is the increased number of patients who qualify for liver transplantation. This broader eligibility can lead to better overall survival rates for patients with liver cancer. Additionally, these criteria have been validated in clinical studies, showing that patients meeting UCSF Criteria have outcomes comparable to those meeting Milan Criteria. This demonstrates that expanding the criteria does not compromise the effectiveness of transplantation.
